Prestige Consumer Healthcare (PBH) Shares Outstanding (Weighted Average) (2010 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Shares Outstanding (Weighted Average) of $48.8 million in Q4 2025, down 0.93% quarter-over-quarter from $49.2 million in Q3 2025, and down 1.63% on a YoY basis from $49.6 million in Q4 2024.

Prestige Consumer Healthcare (PBH) Shares Outstanding (Weighted Average) (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $48.8 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Weighted Average) fell 1.63% year-over-year to $48.8 million; the TTM figure through Dec 2025 stood at $48.8 million (down 1.63% YoY), while the FY2025 annual figure was $49.7 million, changed 0.12% from the prior year.
  • Shares Outstanding (Weighted Average) was $48.8 million for Q4 2025 at Prestige Consumer Healthcare, down from $49.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $50.3 million in Q2 2022 to a low of $48.8 million in Q4 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $49.8 million across 5 years, with a median of $49.8 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) gained 0.25% in 2022, then decreased 1.63% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $50.2 million in 2021, then fell by 1.06% to $49.7 million in 2022, then climbed by 0.08% to $49.7 million in 2023, then fell by 0.27% to $49.6 million in 2024, then declined by 1.63% to $48.8 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $48.8 million (Q4 2025), $49.2 million (Q3 2025), and $49.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Prestige Consumer Healthcare 2.33 Bn 2.26 Bn 157.37 Mn 48.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 48.79 Mn
Sep 30, 2025 49.25 Mn
Jun 30, 2025 49.48 Mn
Mar 31, 2025 49.70 Mn
Dec 31, 2024 49.60 Mn
Sep 30, 2024 49.65 Mn
Jun 30, 2024 49.89 Mn
Mar 31, 2024 49.76 Mn
Dec 31, 2023 49.73 Mn
Sep 30, 2023 49.69 Mn
Jun 30, 2023 49.77 Mn
Mar 31, 2023 49.89 Mn
Dec 31, 2022 49.69 Mn
Sep 30, 2022 50.03 Mn
Jun 30, 2022 50.26 Mn
Mar 31, 2022 50.26 Mn
Dec 31, 2021 50.23 Mn
Sep 30, 2021 50.19 Mn
Jun 30, 2021 50.14 Mn
Mar 31, 2021 50.21 Mn